Share-based Payment Arrangement, Expense in USD of ALX ONCOLOGY HOLDINGS INC from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
ALX ONCOLOGY HOLDINGS INC quarterly and annual Share-based Payment Arrangement, Expense history and change rate from Q2 2019 to Q3 2025.
  • ALX ONCOLOGY HOLDINGS INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,521,000, a 63.7% decline year-over-year.
  • ALX ONCOLOGY HOLDINGS INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $15,731,000, a 43.7% decline year-over-year.
  • ALX ONCOLOGY HOLDINGS INC annual Share-based Payment Arrangement, Expense for 2024 was $27,093,000, a 3.12% increase from 2023.
  • ALX ONCOLOGY HOLDINGS INC annual Share-based Payment Arrangement, Expense for 2023 was $26,273,000, a 10.2% increase from 2022.
  • ALX ONCOLOGY HOLDINGS INC annual Share-based Payment Arrangement, Expense for 2022 was $23,839,000, a 71.3% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

ALX ONCOLOGY HOLDINGS INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $15,731,000 $2,521,000 -$4,431,000 -63.7% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $20,162,000 $2,136,000 -$5,116,000 -70.5% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $25,278,000 $5,216,000 -$1,815,000 -25.8% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $27,093,000 $5,858,000 -$863,000 -12.8% 01 Oct 2024 31 Dec 2024 10-K 06 Mar 2025 2024 FY
Q3 2024 $27,956,000 $6,952,000 -$12,000 -0.17% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025 2025 Q3
Q2 2024 $27,968,000 $7,252,000 +$1,015,000 +16.3% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $26,953,000 $7,031,000 +$680,000 +10.7% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $26,273,000 $6,721,000 +$426,000 +6.77% 01 Oct 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $25,847,000 $6,964,000 +$757,000 +12.2% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 $25,090,000 $6,237,000 +$401,000 +6.87% 01 Apr 2023 30 Jun 2023 10-Q 12 Aug 2024 2024 Q2
Q1 2023 $24,689,000 $6,351,000 +$850,000 +15.5% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $23,839,000 $6,295,000 +$609,000 +10.7% 01 Oct 2022 31 Dec 2022 10-K 06 Mar 2025 2024 FY
Q3 2022 $23,230,000 $6,207,000 +$2,016,000 +48.1% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $21,214,000 $5,836,000 +$3,599,000 +161% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $17,615,000 $5,501,000 +$3,701,000 +206% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 $13,914,000 $5,686,000 +$3,943,000 +226% 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2024 2023 FY
Q3 2021 $9,971,000 $4,191,000 +$3,502,000 +508% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $6,469,000 $2,237,000 -$616,000 -21.6% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $7,085,000 $1,800,000 +$1,649,000 +1092% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $5,436,000 $1,743,000 01 Oct 2020 31 Dec 2020 10-K 09 Mar 2023 2022 FY
Q3 2020 $689,000 +$603,000 +701% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021 2021 Q3
Q2 2020 $2,853,000 +$2,793,000 +4655% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $151,000 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q3 2019 $86,000 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $60,000 01 Apr 2019 30 Jun 2019 10-Q 27 Aug 2020 2020 Q2

ALX ONCOLOGY HOLDINGS INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $27,093,000 +$820,000 +3.12% 01 Jan 2024 31 Dec 2024 10-K 06 Mar 2025 2024 FY
2023 $26,273,000 +$2,434,000 +10.2% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
2022 $23,839,000 +$9,925,000 +71.3% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2025 2024 FY
2021 $13,914,000 +$8,478,000 +156% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2024 2023 FY
2020 $5,436,000 +$5,139,000 +1730% 01 Jan 2020 31 Dec 2020 10-K 09 Mar 2023 2022 FY
2019 $297,000 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.